This year's American Association for the Advancement of Science (AAAS) Annual Meeting February 16-20, 2006 in St. Louis will highlight the growing field of nanotechnology. Mounting excitement about the potential of nanotechnology in life science applications has recently been evidenced by President Bush's State of the Union proposal to double Federal funding over the next 10 years for programs in physical sciences such as nanotech, and by the National Cancer Institute's (NCI) five-year, $144.3 million initiative to integrate nanotechnology into cancer research, diagnosis and treatment. Additionally, the recent American Cancer Society report citing early detection as one of the factors in the first ever annual decline in deaths from cancer underscores the importance of new approaches, such as the use of nanotechnology, to early cancer diagnosis.

St. Louis biotechnology company Kereos is developing one of the most advanced programs using nanotechnology to diagnose and treat cancer and will begin human clinical trials by the end of 2006. Kereos' technology can detect solid tumors of only 1-2 mm in size and is so highly targeted that it can deliver 20-times the chemotherapeutic concentration to the tumor using only 1% of the standard dose. Kereos is also developing its technology for the diagnosis and treatment of cardiovascular disease and presented some of the first data regarding the application of nanotechnology to indications such as atherosclerosis, restenosis and peripheral vascular disease at the American Heart Association 2005 Scientific Sessions. This technology was developed at Washington University in St. Louis, one of the NCI's designated Centers of Cancer Nanotechnology Excellence.

Kereos President and CEO Robert A. Beardsley, Ph.D., will be presenting during the AAAS Annual Meeting on a panel entitled "Science & Engineering Entrepreneurship: Opportunities for the Future" at 10:30 a.m. on Friday, February 17, 2006. Beardsley has led s
'"/>

Contact: Jennifer MacArthur
jmacarthur@pnlifesciences.com
858-527-3497
Porter Novelli, Life Sciences
17-Feb-2006

Page: 1 2
Related biology news :

1. Progenika Biopharma presents a biochip that guarantees safety in blood transfusions
2. SNM presents awards on Capitol Hill
3. ESA presents the sharpest ever satellite map of Earth
4. New book presents neurobiology from an evolutionary perspective
5. Lighting up life: Cold Spring Harbor Protocols presents tips for creating glowing plants
6. Childrens Hospital and Research Center-Oakland presents a new maternal diet study
7. USGS presents a world of science at GSA in Philadelphia
8. Childrens Hospital Boston presents at the 2006 American Academy of Pediatrics National Conference
9. DFG presents the 2006 MAK and BAT value list
10. Childrens Hospital Boston presents at the 2006 Pediatric Academic Societies annual meeting
11. UCB presents positive CIMZIA results from pivotal PHASE III Crohns disease trial at major US medical meeting